Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.31 USD | -0.87% | -0.72% | -29.81% |
04-15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
02-26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
Evolution of the average Target Price on Veracyte, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Veracyte, Inc.
Goldman Sachs | |
Morgan Stanley | |
Needham & Co. | |
Raymond James | |
Scotiabank | |
SVB Securities LLC | |
Stephens Inc. | |
SVB Leerink | |
Lake Street | |
Truist Securities |
EPS Revisions
- Stock Market
- Equities
- VCYT Stock
- Consensus Veracyte, Inc.